EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Twenty years of modelling NPM-ALK-induced lymphomagenesis

Sylvie Giuriato, Suzanne D Turner

Frontiers in Bioscience · 2015 · 7 (2) · 236-247

DOI: 10.2741/s437 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience, 2015. Verfasst von Sylvie Giuriato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Lab Block Level 3, Box 231, Addenbrooke's Hospital, Cambridge…. Hauptthemen laut MEDLINE: Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our current understanding of oncogenic Anaplastic Lymphoma Kinase (ALK)-induced lymphomagenesis has relied for over 20 years on multiple and complementary studies performed on various experimental models, encompassing ALK oncogene expressing cells, their grafts into immune-compromised mice, the generation of genetically engineered mouse models (GEMMs) and, when available, the use of patient samples from Anaplastic Large Cell Lymphoma (ALCL) tumour banks. Of note, and to our knowledge, no ALK-positive ALCL 3D culture system has been described so far. In this review, we will first outline how these different cell and mouse models were designed, and what key findings they revealed (or confirmed) towards oncogenic ALK-induced lymphomagenesis. Secondly, we will discuss how recent and revolutionary advances in genetic engineering technology are likely to complete our understanding of ALK-related disease in an effort to improve current therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalAnaplastic Lymphoma KinaseAnimalsHumansLymphoma, Large-Cell, AnaplasticMiceMice, TransgenicNuclear ProteinsNucleophosminProtein-Tyrosine KinasesReceptor Protein-Tyrosine Kinases

Substanzen

Nuclear ProteinsNucleophosminALK protein, humanAlk protein, mouseAnaplastic Lymphoma KinaseProtein-Tyrosine KinasesReceptor Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Lab Block Level 3, Box 231, Addenbrooke's Hospital, Cambridge CB20QQ, UK, sdt36@cam.ac.uk.

Zitieren

APA

Giuriato, S., & Turner, S. D. (2015). Twenty years of modelling NPM-ALK-induced lymphomagenesis. Frontiers in Bioscience, 7(2), 236-247. https://doi.org/10.2741/s437

Vancouver

Giuriato S, Turner SD. Twenty years of modelling NPM-ALK-induced lymphomagenesis. Frontiers in Bioscience. 2015;7(2):236-247. doi:10.2741/s437

BibTeX
@article{Giuriato2015,
  author = {Giuriato, Sylvie and Turner, Suzanne D},
  title = {Twenty years of modelling NPM-ALK-induced lymphomagenesis},
  journal = {Frontiers in Bioscience},
  year = {2015},
  volume = {7},
  number = {2},
  pages = {236--247},
  doi = {10.2741/s437}
}
Kostenlos starten →